HK Stock Market Move | The concept of traditional Chinese medicine (TCM) is active in the market against the trend. TRAD CHI MED (00570) once rose over 7%. The traditional Chinese medicine industry has received favorable policies.

Traditional Chinese medicine concepts are active against the market. As of the time of writing, TRAD CHI MED (00570) rose by 5.8% to HK$2.19; WAI YUEN TONG (00897) rose by 4.35% to HK$0.36; TONGRENTANGCM (03613) rose by 2.38% to HK$9.03; TONG REN TANG (01666) rose by 1.83% to HK$4.44. On the news front, on February 5th, the Ministry of Industry and Information Technology and eight other departments issued the "Implementation Plan for the High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" (hereinafter referred to as the "Implementation Plan"). It mentioned that by 2030, it will nurture a number of leading Chinese medicine industry leading enterprises with outstanding driving capabilities, cultivate 60 high-standard Chinese medicine raw material production bases. It will promote the approval and listing of a number of innovative Chinese medicine drugs, cultivate 10 new major varieties of Chinese patent medicines, and promote the transformation of a number of medical institutions' Chinese medicine preparations into innovative Chinese medicines. EB SECURITIES stated that the investment logic of the Chinese medicine industry in 2026 will shift from "cost repair" to "value growth". The continuous release of policy dividends and the improvement of corporate operational efficiency will steadily improve industry profitability. With the acceleration of the internationalization of traditional Chinese medicine and the speeding up of the international registration and market expansion of Chinese medicine products, Chinese medicine enterprises with variety advantages and internationalization capabilities are expected to gain new growth space in the global market.